22 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
for Rhythm and continue to execute on our mission of transforming the standard of care for people with rare genetic disorders of obesity.”
“For the more than
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
9 Aug 18
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:07pm
of development, as we continue to execute on our mission of providing new therapies for people living with rare genetic disorders of obesity,” said Keith
8-K
EX-99.2
RYTM
Rhythm Pharmaceuticals Inc.
25 Sep 19
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
8:30am
with it. Solomon, Living with BBS 39 RESEARCH & DEVELOPMENT UPDATE SEPTEMBER 2019
Patient Advocacy Collaborations Advance Common Mission to Improve Lives
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am
mission to transform the lives of patients and families living with hyperphagia and severe obesity caused by rare MC4R pathway diseases,” said David Meeker
8-K
EX-99.1
o817cmdgkg2k2
3 Feb 21
Regulation FD Disclosure
12:00am